BioSpace News Archive

Seqster PDM, Inc. (“Seqster”), the leader in patient-centric healthcare data technology announced a 3-year partnership with Boehringer Ingelheim to connect the patients to all of their health data.

Eiger BioPharmaceuticals, Inc. today announced that it will host a conference call on Thursday, August 4, 2022 at 4:30 PM ET to discuss its second quarter 2022 financial results and provide a business update.

Mission Bio, Inc. today announced the initial availability of the industry’s first assay capable of determining measurable residual disease (MRD) in cancer down to the level of individual cells, launching a new era for the understanding of disease progression.

Equillium Announces Presentation at the 3rd Annual Cytokine-Based Drug Development Summit.

Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company developing STAR-0215 for hereditary angioedema and focused on life-changing therapies for rare and niche allergic and immunological diseases, today announced the U.S. Food and Drug Administration (FDA) clearance of its Investigational New Drug (IND) application for STAR-0215, which the company is developing for the treatment of Hereditary Angioedema (HAE).

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the second quarter ended June 30, 2022 and reviewed recent business highlights.

Cybin to Present at the Canaccord Genuity 42nd Annual Growth Conference.

Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced that it will release financial results for the second quarter of 2022 after the close of trading on Thursday, August 11, 2022.

Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for the management of breast and prostate cancers, today announced that it will report financial results for its fiscal 2022 third quarter, on Thursday, August 11, 2022, before the market opens.

Company to Host Conference Call and Webcast on August 10.